Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI


Primary Symbol: V.BTI.H Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by craighenryon Dec 27, 2022 6:12pm
81 Views
Post# 35192880

RE:RE:This shows how the Financing Market is out there

RE:RE:This shows how the Financing Market is out there
Boomskid wrote: The expert, craighenry, states that without the Midatech deal Bioasis would have to declare Chapter 11.

Why would a Canadian company declare bankruptcy using American Chapter 11 bankruptcy laws? Could they do that? Nah.

Besides, if Chapter 11 or Canada's equivalent CCAA could be used, then Bioasis could be given time to raise money and to make payment arrangements with creditors.

With Dr. Rathjen out of the way at that unlikely point, maybe the money could be found. It would be better to lose half the company to the dilution of equity financings that 90% of it to LT & The Placee, and to then see xB3 go someplace else, just to rub a real good dose of salt in the wounds.

Gee, whiz, craig! Embarrassing.

JD


"Money could be found" yeah!!

Good one JD.


How many failed financings did DR attempt?


Lolololol



What a clown

<< Previous
Bullboard Posts
Next >>